| Description |
1 online resource (vi, 206 pages) : illustrations |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Series |
Evidence synthesis program |
|
Evidence-based synthesis program (Series)
|
| Note |
"December 2019." |
| Bibliography |
Includes bibliographical references (pages 51-63). |
| Funding |
VA ESP 09-009 |
| Note |
Online resource; title from PDF cover (VA, viewed October 16, 2020). |
| Summary |
More than 40% of people in the United States age great than or equal to 65 years take 5 or more prescription medications on a regular basis to control and/or prevent disease symptoms and complications. Exposure to multiple medications, known as polypharmacy, is associated with increased risk of negative outcomes, such as falls, cognitive impairment and other geriatric syndromes, hospitalizations, and death. The number of medications a person is taking may be the single most important predictor of adverse drug effects. Furthermore, about 50% of older adults are taking 1 or more potentially inappropriate medications (PIMs), including those without a clear indication, duplicative medications, and medications known to pose risks in the elderly. Efforts have been underway for more than 30 years to develop and test interventions to mitigate the adverse effects of polypharmacy and inappropriate medication use. Initially, drug discontinuation efforts were focused on stopping specific medications considered to be problematic in older adults. This has evolved into a more holistic approach, called "deprescribing", that considers medications in the context of the individual's co-morbidities, functional status, treatment goals, and life expectancy. Deprescribing has been defined as "the clinically supervised process of stopping or reducing the dose of medications when they cause harm or no longer provide benefit". The Center for Medication Safety in Aging, a VA Patient Safety Center of Inquiry, was charged with development and implementation of deprescribing approaches in VA settings. The purpose of this evidence review, commissioned by the National Center for Patient Safety and endorsed by the VHA Pharmacy Benefits Management and the Geriatrics and Extended Care Services, is to inform that work |
| Subject |
Drugs -- Prescribing -- United States.
|
|
Older veterans -- United States.
|
|
Drugs -- Dosage -- Reduction.
|
|
Older people.
|
|
Polypharmacy.
|
|
Deprescriptions |
|
Aged |
|
Drug-Related Side Effects and Adverse Reactions -- prevention & control |
|
Inappropriate Prescribing -- adverse effects |
|
Polypharmacy |
|
Médicaments -- Prescription -- États-Unis.
|
|
Anciens combattants âgés -- États-Unis.
|
|
Posologie -- Diminution.
|
|
Personnes âgées.
|
|
Polypharmacie.
|
|
elderly.
|
|
Polypharmacy
|
|
Older people
|
|
Drugs -- Dosage -- Reduction
|
|
Drugs -- Prescribing
|
|
Older veterans
|
|
United States https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
| Genre/Form |
Systematic Review |
|
Revues systématiques.
|
| Added Author |
United States. Department of Veterans Affairs. Health Services Research and Development Service, issuing body.
|
| Standard No. |
NLM 101772453 |
|
AU@ 000075698501 |
| Gpo Item No. |
0985-A-12 (online) |
| Sudoc No. |
VA 1.107/3:D 44/2 |
|
